Probabilistic index: An intuitive non-parametric approach to measuring the size of treatment effects

Statistics in Medicine

Volumn 25, Issue 4, 2006, Pages 591-602

  Acion, Laura ^a,c   Peterson, John J ^b   Temple, Scott ^c   Arndt, Stephan ^a,c  

^a UNIVERSITY OF IOWA   (United States)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Area under the curve; Effect size; Kendall's ; Mann Whitney U statistic; P(X > Y)

Indexed keywords

NEUROLEPTIC AGENT;

AREA UNDER THE CURVE; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; EFFECT SIZE; HUMAN; NONPARAMETRIC TEST; PROBABILITY; RANK SUM TEST; ROC CURVE; SCHIZOPHRENIA; STANDARDIZATION; TREATMENT OUTCOME;

CLINICAL TRIALS; COGNITIVE THERAPY; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MALE; ROC CURVE; SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 31744450801     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2256     Document Type: Article

References (35)

1. Rao CR. Statistics: reflections on the past and visions for the future. Amstat News 2004; (327):2-3.
2. Editorial. Statistically significant. Nature Medicine 2005; 11(1):1.
3. Rosenthal R, Rosnow RL, Rubin DB. Contrasts and Effect Sizes in Behavioral Research: A Correlational Approach. Cambridge University Press: New York, 1999.
4. Fidler F, Thomason N, Cumming G, Finch S, Leeman J. Editors can lead researchers to confidence intervals, but can't make them think. Psychological Science 2004; 15(2):119-126.
5. Church J, Harris B. The estimation of reliability from stress-strength relationships. Technometrics 1970; 12(1): 49-54.
6. Hauck W, Hyslop T, Anderson S. Generalized treatment effects for clinical trials. Statistics in Medicine 2000; 19:887-899.
7. McGraw K, Wong S. A common language effect size statistic. Psychological Bulletin 1992; 111(2):361-365.
8. Grissom R. Probability of the superior outcome of one treatment over another. Journal of Applied Psychology 1994; 79(2):314-316.
9. Kraemer H, Morgan G, Leech N, Gliner J, Vaske J, Harmon R. Measures of clinical significance. Journal of the American Academy of Child and Adolescent Psychiatry 2003; 42(12):1524-1529.
10. Kraemer H. Statistics and clinical trial design in psychopharmacology. Textbook of Psychopharmacology. American Psychiatric Publishing Inc.: Washington, DC, 2004; 173-183.
11. Fern E, Monroe K. Effect-size estimates: issues and problems in interpretation. Journal of Consumer Research 1996; 23:89-105.
12. Olejnik S, Algina J. Measures of effect size for comparative studies: applications, interpretations, and limitations. Contemporary Educational Psychology 2000; 25:241-286.
13. Sanchez-Meca J, Marin-Martinez F, Chacon-Moscoso S. Effect-size indices for dichotomized outcomes in meta-analysis. Psychological Methods 2003; 8(4):448-467.
14. Kirk R. Practical significance: a concept whose time has come. Educational and Psychological Measurement 1996; 56(5):746-759.
15. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum Associates: Hillsdale, NJ, 1988.
16. Olejnik S, Algina J. Generalized eta and omega squared statistics: measures of effect size for some common research designs. Psychological Methods 2003; 8(4):434-447.
17. Huberty C. A history of effect size indices. Educational and Psychological Measurement 2002; 62(2):227-240.
18. Hedges LV, Olkin I. Statistical Methods for Meta-analysis. Academic Press: New York, 1985.
19. Hanley J, McNeil B. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-36.
20. Wolfe D, Hogg R. On constructing statistics and reporting data. The American Statistician 1971; 25(4):27-30.
21. Lehmann E. Consistency and unbiasedness of certain nonparametric tests. Annals of Mathematical Statistics 1951; 22:165-179.
22. Lehmann E. Nonparametrics: Statistical Methods Based on Ranks. Prentice-Hall: Upper Saddle River, NJ, 1998.
23. Kerridge D. The interpretation of rank correlations. Applied Statistics 1975; 24:257-258.
24. Kendall M, Gibbons JD. Rank Correlation Methods. Oxford University Press: New York, 1990.
25. Temple S, Ho B. Cognitive therapy for persistent psychosis in schizophrenia: a case-controlled clinical trial. Schizophrenia Research, in press.
26. Brunner E, Domhof S, Langer F. Nonparametric Analysis of Longitudinal Data in Factorial Experiments. Wiley: New York, 2001.
27. StataCorp. Stata Statistical Software: Release 8.0. Stata Corporation: College Station, TX, 2003.
28. SAS Institute Inc. SAS Online Doc®Version 9. SAS Institute Inc.: Cary, NC, 2002.
29. Hintze J. NCSS and PASS. Number Cruncher Statistical Systems. Kaysville, Utah. WWW.NCSS.COM, 2004.
30. Altman D, Schulz K, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche P, Lang T. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Annals of Internal Medicine 2001; 134(8):663-694.
31. Cook R, Sackett D. The number needed to treat: a clinically useful measure of treatment effect. British Medical Journal 1995; 310:452-454.
32. Miller R. Gehan test. Survival Analysis. Wiley: New York, 1981; 91.
33. VanDantzig D. On the consistency and the power of Wilcoxon's two sample test. Koninklidje Akademie Wetenschappen Proceedings 1951; 54(Series A):1-8.
34. Noether G. Sample size determination for some common nonparametric tests. Journal of the American Statistical Association 1987; 82(398):645-647.
35. Mee R. Confidence intervals for probabilities and tolerance regions based on a generalization of the Mann-Whitney statistic. Journal of the American Statistical Association 1990; 85(411):793-800.